Dr. Shin currently serves as Chief of Breast Pathology and Director of the Comprehensive Breast Pathology Consultation Service at the New York Presbyterian Hospital-Weill Cornell Medical College (NYPH-WCMC). She completed her anatomic and clinical pathology training and one-year breast pathology fellowship with Dr. Paul Peter Rosen at the New York Presbyterian Hospital-Cornell campus. After spending a year investigating molecular alterations in breast disease in the molecular pathology laboratory of Dr. Daniel M. Knowles, she joined the faculty in 2001. In addition to her clinical service work, Dr. Shin spends her time conducting translational research in breast disease which has led to numerous peer-reviewed scientific publications including chapters in Diagnostic Immunohistochemistry (3 editions), World Health Organization (WHO) Classification of Tumors of the Breast (4th edition), and an upcoming breast pathology textbook. Her scholarly involvement in breast pathology extends into national and international forums, notably her serving as a scientist grant reviewer for the Department of Defense Breast Cancer Research Program for many years and involvement in the United States & Canadian Academy of Pathology (USCAP) annual meeting as a abstract reviewer, moderator for the breast platform sessions, and expert panelist at the evening subspecialty conference. Recently, she was invited to participate in the WHO consensus editorial meeting in Lyon, France as well as is a member of the expert breast pathology committee for the National Cancer Institute (NC)/ The Cancer Genoma Atlas (TCGA). She has also given numerous invited lectures on the topic of breast disease across the country as well as internationally (including Mexico, South Korea, Hong Kong) and is a reviewer for multiple medical journals. She is the director of long courses in breast pathology held at the annual meetings of College of American Pathologists (CAP) and American Society of Clinical Pathologists (ASCP). Recently, she established and now directs the one-year Breast Pathology Fellowship Program offered at NYPH-WCMC. She is also receives extramural funding including an R01 NIH/NCI grant in breast cancer research for which she is a co-PI.
